Press Releases


Eastgate Biotech Corp (OTC: ETBI) Management Interview

Eastgate Biotech Corp (OTC: ETBI) Management Interview


Interview with COO Bill Abajian

Eastgate’s new COO took time to discuss his role with the company, ETBI’s licensing strategy, and upcoming goals for the next few months which includes the commencement of the Phase III trial for their flagship product, Insugin.



 EastGate Biotech (OTCBB: ETBI) produces and distributes innovative and healthy nutraceuticals that are based on natural therapies and absorbed naturally by the body. We utilize state-of-the-art nanotechnologies to deliver healthy alternatives to conventional pharmaceuticals that all-too-often create dangerous side-effects and unexpected consequences for those trying to attain and maintain healthy lives. Our research and development scientists have more than 60 years of combined experience and are dedicated to providing the best nutraceutical products for your natural comfort, health, and well-being. We invite you to explore the naturally healthy benefits of EastGate Pharma.

Leave a Reply

Your email address will not be published. Required fields are marked *